Clinical trial
A Prospective, Multicentre, Open Labelled, Single Arm Phase-IV Clinical Trial of Niraparib in Indian Patients With Advanced or Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy
NCT06887933 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicentre, Open Labelled, Single Arm Phase-IV Clinical Trial of Niraparib in Indian Patients With Advanced or Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- April 22, 2025
- Completion date
- July 8, 2026
- Enrollment
- 67 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.